The store will not work correctly when cookies are disabled.
(5-amino-3'-(trifluoromethyl)biphenyl-2-yl)(2-chlorophenyl)methanone
ID: ALA4293341
PubChem CID: 145988118
Max Phase: Preclinical
Molecular Formula: C20H13ClF3NO
Molecular Weight: 375.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(C(=O)c2ccccc2Cl)c(-c2cccc(C(F)(F)F)c2)c1
Standard InChI: InChI=1S/C20H13ClF3NO/c21-18-7-2-1-6-16(18)19(26)15-9-8-14(25)11-17(15)12-4-3-5-13(10-12)20(22,23)24/h1-11H,25H2
Standard InChI Key: QVMQHDGGAVIKDQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
35.2187 -18.2955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2196 -19.1205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9292 -17.8843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2519 -16.6413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9710 -17.0505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6765 -16.6286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6674 -15.8029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9470 -15.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2404 -15.8211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5022 -19.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5028 -20.3575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2188 -20.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9316 -20.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9276 -19.5295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6407 -19.1117 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
37.3927 -17.0296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4035 -17.8503 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.0981 -16.6098 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.1001 -17.4373 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.5108 -17.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5418 -17.0640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8416 -16.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1099 -17.0128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0827 -17.8438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7837 -18.2790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4136 -16.5780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20 1 1 0
1 2 1 0
1 3 2 0
21 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
2 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 2 1 0
14 15 1 0
6 16 1 0
16 17 1 0
16 18 1 0
16 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 375.78 | Molecular Weight (Monoisotopic): 375.0638 | AlogP: 5.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 43.09 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 2.59 | CX LogP: 5.73 | CX LogD: 5.73 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.46 | Np Likeness Score: -1.05 |
References
1. Doebelin C, Patouret R, Garcia-Ordonez RD, Chang MR, Dharmarajan V, Novick S, Ciesla A, Campbell S, Solt LA, Griffin PR, Kamenecka TM.. (2018) Identification of potent RORβ modulators: Scaffold variation., 28 (19): [PMID:30143422] [10.1016/j.bmcl.2018.08.017] |